Variant report
Variant | esv2461229 |
---|---|
Chromosome Location | chr13:48032464-48033865 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:140)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr13:48033654-48033999 | IMR90 | lung: | n/a | chr13:48033813-48033826 |
2 | CEBPB | chr13:48033652-48033970 | MCF-7 | breast: | n/a | chr13:48033813-48033826 |
3 | CEBPB | chr13:48033660-48033989 | Hela-S3 | cervix: | n/a | chr13:48033813-48033826 |
4 | CEBPB | chr13:48033704-48033972 | H1-hESC | embryonic stem cell: | n/a | chr13:48033813-48033826 |
5 | CTCF | chr13:48033778-48033895 | LNCaP | prostate: | n/a | n/a |
6 | CTCF | chr13:48033780-48033930 | HBMEC | blood vessel: | n/a | n/a |
7 | CTCF | chr13:48033770-48033907 | HepG2 | liver: | n/a | n/a |
8 | CTCF | chr13:48033736-48033950 | Gliobla | brain: | n/a | n/a |
9 | CTCF | chr13:48033720-48033870 | GM12874 | blood: | n/a | n/a |
10 | CTCF | chr13:48033709-48033909 | K562 | blood: | n/a | n/a |
11 | CTCF | chr13:48033720-48033870 | GM12873 | blood: | n/a | n/a |
12 | CTCF | chr13:48033760-48033910 | SK-N-SH_RA | brain: | n/a | n/a |
13 | CTCF | chr13:48033813-48033871 | GM13976 | blood: | n/a | n/a |
14 | CTCF | chr13:48033780-48033930 | HPF | lung: | n/a | n/a |
15 | CTCF | chr13:48033720-48033870 | HCFaa | heart: | n/a | n/a |
16 | CTCF | chr13:48033780-48033930 | HAc | cerebellar: | n/a | n/a |
17 | CTCF | chr13:48033760-48033910 | HL-60 | blood: | n/a | n/a |
18 | CTCF | chr13:48033669-48034017 | GM12878 | blood: | n/a | n/a |
19 | CTCF | chr13:48033760-48033910 | GM12872 | blood: | n/a | n/a |
20 | CTCF | chr13:48033805-48033988 | Medullo | brain: | n/a | n/a |
21 | CTCF | chr13:48033740-48033890 | GM12873 | blood: | n/a | n/a |
22 | CTCF | chr13:48033760-48033910 | HPAF | blood vessel: | n/a | n/a |
23 | CTCF | chr13:48033754-48033891 | MCF-7 | breast: | n/a | n/a |
24 | CTCF | chr13:48033800-48033950 | GM12866 | blood: | n/a | n/a |
25 | CTCF | chr13:48033720-48033870 | GM12872 | blood: | n/a | n/a |
26 | CTCF | chr13:48033780-48033930 | GM12865 | blood: | n/a | n/a |
27 | CTCF | chr13:48033740-48033890 | AG09319 | gingival: | n/a | n/a |
28 | CTCF | chr13:48033784-48033904 | GM10266 | blood: | n/a | n/a |
29 | CTCF | chr13:48033740-48033890 | Caco-2 | colon: | n/a | n/a |
30 | CTCF | chr13:48033780-48033930 | GM12867 | blood: | n/a | n/a |
31 | CTCF | chr13:48033742-48033858 | Fibrobl | skin: | n/a | n/a |
32 | CTCF | chr13:48033660-48033810 | HFF-Myc | foreskin: | n/a | n/a |
33 | CTCF | chr13:48033740-48033890 | AG09309 | skin: | n/a | n/a |
34 | CTCF | chr13:48033740-48033890 | NHDF-neo | bronchial: | n/a | n/a |
35 | CTCF | chr13:48033729-48033902 | T-47D | breast: | n/a | n/a |
36 | CTCF | chr13:48033760-48033910 | HMF | breast: | n/a | n/a |
37 | CTCF | chr13:48033700-48033850 | GM12875 | blood: | n/a | n/a |
38 | CTCF | chr13:48033760-48033910 | BE2_C | brain: | n/a | n/a |
39 | CTCF | chr13:48033700-48033850 | GM12864 | blood: | n/a | n/a |
40 | CTCF | chr13:48033782-48033904 | K562 | blood: | n/a | n/a |
41 | CTCF | chr13:48033780-48033930 | HVMF | connective: | n/a | n/a |
42 | CTCF | chr13:48033760-48033910 | AG04450 | lung: | n/a | n/a |
43 | CTCF | chr13:48033744-48033921 | MCF-7 | breast: | n/a | n/a |
44 | CTCF | chr13:48033780-48033930 | AG09319 | gingival: | n/a | n/a |
45 | CTCF | chr13:48033780-48033930 | GM12874 | blood: | n/a | n/a |
46 | CTCF | chr13:48033740-48033890 | GM12878 | blood: | n/a | n/a |
47 | CTCF | chr13:48033623-48033943 | MCF-7 | breast: | n/a | n/a |
48 | CTCF | chr13:48033780-48033930 | AoAF | blood vessel: | n/a | n/a |
49 | CTCF | chr13:48033740-48033890 | HFF | foreskin: | n/a | n/a |
50 | CTCF | chr13:48033800-48033950 | HRPEpiC | eye: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SUCLA2-11 | chr13:48033078-48033369 | NONHSAT033680 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RN7SL700P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs369257814 | chr13:48032515-48032516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574320517 | chr13:48032563-48032564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541447237 | chr13:48032609-48032610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372987975 | chr13:48032661-48032662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs114348296 | chr13:48032681-48032682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182871054 | chr13:48032692-48032693 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73182288 | chr13:48032714-48032715 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs146659193 | chr13:48032721-48032722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567014070 | chr13:48032768-48032769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs528292047 | chr13:48032782-48032783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573021989 | chr13:48032821-48032822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568359664 | chr13:48032824-48032825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9595711 | chr13:48032831-48032832 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs562056546 | chr13:48032852-48032853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs77730722 | chr13:48032862-48032863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186682452 | chr13:48032892-48032893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148859746 | chr13:48032895-48032896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550600691 | chr13:48032923-48032924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143480186 | chr13:48032939-48032940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192574660 | chr13:48032959-48032960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535237040 | chr13:48032980-48032981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553365545 | chr13:48033023-48033024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371835063 | chr13:48033112-48033113 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs150990210 | chr13:48033132-48033133 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs542153111 | chr13:48033133-48033134 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs140806207 | chr13:48033135-48033136 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs546294116 | chr13:48033173-48033174 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs183529258 | chr13:48033205-48033206 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs9567866 | chr13:48033224-48033225 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs545444250 | chr13:48033238-48033239 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs564215475 | chr13:48033314-48033315 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs546700428 | chr13:48033321-48033322 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs566427629 | chr13:48033359-48033360 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs536084919 | chr13:48033361-48033362 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs116228041 | chr13:48033362-48033363 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs540444250 | chr13:48033388-48033389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9567867 | chr13:48033401-48033402 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs529186348 | chr13:48033406-48033407 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550933508 | chr13:48033416-48033417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570019170 | chr13:48033428-48033429 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9526336 | chr13:48033464-48033465 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs146184550 | chr13:48033534-48033535 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs377484556 | chr13:48033540-48033541 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs570946392 | chr13:48033544-48033545 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs534837546 | chr13:48033579-48033580 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs569211328 | chr13:48033620-48033621 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs547158398 | chr13:48033628-48033629 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs111573692 | chr13:48033630-48033631 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs370730857 | chr13:48033647-48033648 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs193192010 | chr13:48033650-48033651 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 21088497 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22048815 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 21858162 | CNVD |
Cancer | 17699850 | CNVD |
Ovarian cancer | 17699850 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:48029800-48033200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr13:48029800-48033400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr13:48029800-48033600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
4 | chr13:48029800-48033600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr13:48029800-48033800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
6 | chr13:48029800-48037400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr13:48030000-48033600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
8 | chr13:48030000-48033600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
9 | chr13:48030200-48033400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
10 | chr13:48031800-48033400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr13:48031800-48033400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr13:48031800-48033400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
13 | chr13:48032000-48036000 | Weak transcription | Hela-S3 | cervix |
14 | chr13:48033200-48034000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr13:48033400-48033800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr13:48033400-48033800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr13:48033400-48033800 | Enhancers | Muscle Satellite Cultured Cells | -- |
18 | chr13:48033400-48034400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
19 | chr13:48033400-48034400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
20 | chr13:48033400-48034600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr13:48033600-48033800 | Enhancers | H1 Cell Line | embryonic stem cell |
22 | chr13:48033600-48034200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
23 | chr13:48033600-48034200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
24 | chr13:48033600-48034200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
25 | chr13:48033600-48034400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
26 | chr13:48033800-48034400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
27 | chr13:48033800-48037600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
28 | chr13:48033800-48037800 | Weak transcription | H1 Cell Line | embryonic stem cell |
29 | chr13:48033800-48037800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
30 | chr13:48033800-48038000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |